Recent Press Releases

Biogen Reports First Quarter 2015 Revenues of $2.6 Billion

Multiple sclerosis portfolio gains share globally with ongoing TECFIDERA® rollout in Europe and launch of PLEGRIDY® Company advances research pipeline and development efforts in...

Mylan To Commence Formal Offer To Acquire Perrigo For US$60 In Cash And 2.2 Mylan Shares Per Perrigo Share

POTTERS BAR, England, April 24, 2015 /PRNewswire/ -- On 8 April 2015, Mylan N.V. (NASDAQ: MYL) issued a Rule 2.4 announcement under the Irish Takeover Rules stating that it had made a non-binding...

Bristol-Myers Squibb Receives Positive CHMP Opinion in the European Union for Opdivo (nivolumab) for the Treatment of Advanced Melanoma in Both First-Line and Previously Treated Patients

Bristol-Myers Squibb Receives Positive CHMP Opinion in the European Union for Opdivo (nivolumab) for the Treatment of Advanced Melanoma in Both First-Line and Previously Treated Patients April 24,...

New treatment for advanced melanoma

New treatment for advanced melanoma Opdivo offers treatment option for patients with poor prognosis The European Medicines Agency (EMA) has recommended granting a marketing authorisation for Opdivo...

ASTRAZENECA ANNOUNCES FIRST QUARTER RESULTS 2015

Financial results for Q1 2015 support reiterated 2015 guidance. Total Revenue (defined as Product Sales and Externalisation Revenue1) grew by 1% at constant exchange rates2 to $6,057m (Q1 2014:...

Lilly Reports First-Quarter 2015 Results

INDIANAPOLIS, April 23, 2015 /PRNewswire/ --

AbbVie Reports First-Quarter 2015 Financial Results

- Reports First-Quarter Adjusted EPS of $0.94, Up 32.4 Percent and Exceeding Previous Guidance Range of $0.82 to $0.84 (Reports GAAP EPS of $0.63) - Delivers First-Quarter Revenue of $5.040...

Lilly Reports First-Quarter 2015 Results

Lilly Reports First-Quarter 2015 Results INDIANAPOLIS, April 23, 2015 /PRNewswire/ -- Revenue declined 1 percent due to the unfavorable impact of foreign exchange rates and the continuing impact of...

Mylan Launches Generic Sofosbuvir Tablets, MyHep(TM), in India

POTTERS BAR, England and HYDERABAD, India, April 23, 2015 /PRNewswire/ -- Mylan N.V. (Nasdaq: MYL) today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has launched generic...

Key Trends in the Pharmaceutical and Nutritional Supplement Industries Outperforming Other Industries as Increase in Pharma Grade Products & Supplements Grow Globally

Company Signs Major New Agreement with Chinese Manufacturer

CORAL SPRINGS, Florida, April 22, 2015 /

Tim McGraw, Merck and the American Diabetes Association Challenge Americans with Type 2 Diabetes to Get to Their A1C Goal

Platinum-Recording Artist and Actor Rallies People to Make a Pledge with America's Diabetes Challenge: Get to Your Goals Program

KENILWOR

Abbott Reports First-Quarter 2015 Results

- FIRST-QUARTER DOUBLE-DIGIT OPERATIONAL SALES GROWTH

ABBOTT PARK, Ill., April 22, 2015 /PRNewswire/ -- Abbott (NYSE: ABT) 

Transgene Presents New Data with TG1050, an Immunotherapy Being Developed to Treat Chronic Hepatitis B, at The International Liver Congress™ 2015

Transgene Presents New Data with TG1050, an Immunotherapy Being Developed to Treat Chronic Hepatitis B, at The International Liver Congress™ 2015

Regulatory News:

Teva Files for Hart-Scott-Rodino Notification Regarding Proposed Acquisition of Mylan

Reiterates Commitment to Consummating the Combination of Teva and Mylan JERUSALEM--(BUSINESS WIRE)--Apr. 22, 2015-- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) (TASE:TEVA) today announced that it...

Big Data and Genomics Meet the Cloud: the First Unified Global Platform for Precision Medicine

SHANGHAI; CAMBRIDGE, Mass.; and MOUNTAIN VIEW, Calif., April 22, 2015 – WuXi PharmaTech (Cayman) Inc. ($WX), whose leading open-access R&D capability and technology platform serves the...

Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48

First Quarter 2015 GAAP EPS Were $2.11

THOUSAND OAKS, Calif., April 21, 2015 /PRNewswire/ -- Amgen (

Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan

This is an announcement falling under Rule 2.4 of Irish Takeover Panel Act, 1997, Takeover Rules, 2013 (the "Irish Takeover Rules"). Proposal Substantially Undervalues Perrigo and is...

Teva Proposes to Acquire Mylan for $82.00 Per Share in Cash and Stock

Combination to Create an Industry-Leading Company, Well Positioned to Transform the Global Generics Space and Create a Unique and Differentiated Business Model, Leveraging on Its Significant Assets...

Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis

INDIANAPOLIS, April 20, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the inves